Greco Carla, Nascimbeni Fabio, Carubbi Francesca, Andreone Pietro, Simoni Manuela, Santi Daniele
Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 42121 Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile di Baggiovara, 41125 Modena, Italy.
J Clin Med. 2021 Sep 28;10(19):4466. doi: 10.3390/jcm10194466.
The relationship between nonalcoholic fatty liver disease (NAFLD) and diabetic polyneuropathy (DPN) has been demonstrated in many studies, although results were conflicting. This meta-analysis aims to summarize available data and to estimate the DPN risk among NAFLD patients.
We performed a comprehensive literature review until 4 June 2021. Clinical trials analyzing the association between NAFLD and DPN were included.
Thirteen studies (9614 participants) were included. DPN prevalence was significantly higher in patients with NALFD, compared to patients without NAFLD (OR (95%CI) 2.48 (1.42-4.34), = 0.001; I2 96%). This finding was confirmed in type 2 diabetes (OR (95%CI) 2.51 (1.33-4.74), = 0.005; I2 97%), but not in type 1 diabetes (OR (95%CI) 2.44 (0.85-6.99), = 0.100; I2 77%). Also, body mass index and diabetes duration were higher in NAFLD subjects compared to those without NAFLD ( < 0.001), considering both type 2 and type 1 diabetes.
Despite a high heterogeneity among studies, a significantly increased DPN prevalence among type 2 diabetes subjects with NAFLD was observed. This result was not found in type 1 diabetes, probably due to the longer duration of disease. Physicians should pay more attention to the early detection of DPN, especially in patients with NAFLD.
尽管许多研究结果相互矛盾,但非酒精性脂肪性肝病(NAFLD)与糖尿病性多发性神经病(DPN)之间的关系已得到证实。本荟萃分析旨在总结现有数据,并评估NAFLD患者发生DPN的风险。
我们进行了全面的文献综述,截至2021年6月4日。纳入分析NAFLD与DPN之间关联的临床试验。
纳入13项研究(9614名参与者)。与无NAFLD的患者相比,NAFLD患者的DPN患病率显著更高(OR(95%CI)2.48(1.42 - 4.34),P = 0.001;I² 96%)。在2型糖尿病患者中也得到了这一结果(OR(95%CI)2.51(1.33 - 4.74),P = 0.005;I² 97%),但在1型糖尿病患者中未得到此结果(OR(95%CI)2.44(0.85 - 6.99),P = 0.100;I² 77%)。此外,考虑2型和1型糖尿病,NAFLD患者的体重指数和糖尿病病程均高于无NAFLD的患者(P < 0.001)。
尽管研究之间存在高度异质性,但观察到2型糖尿病合并NAFLD患者的DPN患病率显著增加。在1型糖尿病中未发现此结果,可能是由于病程较长。医生应更加关注DPN的早期检测,尤其是NAFLD患者。